CXCL12 and neoplasm: The effects of MI-319 appear to be at least in part due to the ability of the drug to suppress the influx of MDSC into the tumor, which may in turn be due to its ability to block the production of chemokines such as SDF-1 that are otherwise induced in the setting of hypoxia.